CANNARA BIOTECH INC (LOVE.CA) Stock Balance Sheet
TSX-V:LOVE • CA13765U2002
1.84 CAD
0 (0%)
Last: Mar 10, 2026, 07:00 PM
| MRQ (2025-11-30) | 2025 (2025-8-31) | 2024 (2024-8-31) | 2023 (2023-8-31) | 2022 (2022-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 16.52M | 14.36M | 6.62M | 4.27M | 12.11M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 15.22M | 14.11M | 13.04M | 10.59M | 8.62M | |||
| Inventories | 51.97M | 51.33M | 40.07M | 33.77M | 18.98M | |||
| Other Current Assets | 1.33M | 2.36M | 7.74M | 3.06M | 1.28M | |||
| Total Current Assets | 85.04M | 82.16M | 67.47M | 51.70M | 40.99M | |||
| Non-Current Assets | ||||||||
| PPE Net | 88.19M | 86.00M | 84.94M | 89.44M | 83.40M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 620.10K | 487.80K | 2.31M | 389.70K | 1.22M | |||
| Total Non-Current Assets | 88.81M | 86.49M | 87.25M | 89.83M | 84.63M | |||
| TOTAL ASSETS | 173.84M | 168.65M | 154.72M | 141.52M | 125.62M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 6.76M | 6.76M | 6.26M | 3.00M | 0.00 | |||
| Current Portion Of LT Debt. | 2.38M | 6.54M | 3.25M | 3.04M | 2.19M | |||
| Accrued Expenses | 10.09M | 9.77M | 7.79M | 1.57M | 826.60K | |||
| Accounts Payable | 12.14M | 11.00M | 9.58M | 13.41M | 8.80M | |||
| Other Current Liabilities | 125.40K | 133.30K | 134.80K | 160.90K | 45.20K | |||
| Total Current Liabilities | 31.50M | 34.20M | 27.00M | 21.18M | 11.86M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 25.67M | 28.28M | 38.82M | 39.74M | 46.20M | |||
| Deferred Taxes/Income | 4.07M | 3.07M | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 1.40M | 878.20K | 945.00K | 856.80K | 816.50K | |||
| Total Non-Current Liabilities | 31.13M | 32.23M | 39.77M | 40.60M | 47.02M | |||
| TOTAL LIABILITIES | 62.63M | 66.43M | 66.77M | 61.78M | 58.88M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 1.22M | 178.30K | -12.90M | -19.34M | -26.30M | |||
| Additional Paid In Capital | 12.76M | 12.28M | 12.33M | 10.35M | 9.72M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 97.24M | 89.76M | 88.52M | 88.80M | 83.30M | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | -69.30K | 15.10K | |||
| Shares Outstanding | 94.90M | 91.43M | 90.02M | 90.31M | 87.70M | |||
| Tangible Book Value per Share | 1.17 | 1.12 | 0.98 | 0.88 | 0.76 | |||
| Total Shareholders' Equity | 111.21M | 102.22M | 87.95M | 79.74M | 66.74M | |||
| TOTAL LIABILITIES AND EQUITY | 173.84M | 168.65M | 154.72M | 141.52M | 125.62M | |||
| Statistics | ||||||||
| Debt/Equity | 0.29 | 0.34 | 0.51 | 0.54 | 0.69 | |||
| Current Ratio | 2.70 | 2.40 | 2.50 | 2.44 | 3.46 | |||
| Return On Assets (ROA) | 6.79% | 7.75% | 4.16% | 4.91% | 1.84% | |||
| Return On Equity (ROE) | 10.62% | 12.79% | 7.32% | 8.71% | 3.45% | |||
All data in CAD , ROIC based on taxRate of 0.28